In the present study, we retrospectively examined the clinical characteristics of patients with KRAS‐positive lung cancer who underwent plasma NGS analysis using the ION Torrent Genexus System (Genexus)/Oncomine Precision Assay (OPA) in a previous study15 conducted at our hospital. This evidence concerns the gene KRAS and lung cancer.